Factor VII anticorps
Aperçu rapide pour Factor VII anticorps (ABIN7673037)
Antigène
Voir toutes Factor VII (F7) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Fonction
- F7 antibody
-
Purification
- Immunogen affinity purified
-
Pureté
- ≥95 % as determined by SDS-PAGE
-
Immunogène
- coagulation factor VII(serum prothrombin conversion accelerator)
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB: 1:500-1:2000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freeze / thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
-
Date de péremption
- 12 months
-
-
- Factor VII (F7) (Coagulation Factor VII (F7))
-
Autre désignation
- F7
-
Sujet
-
Synonyms: Coagulation factor VII|Proconvertin|Serum prothrombin conversion accelerator (SPCA)|Factor VII light chain|Factor VII heavy chain|F7
Background: Initiates the extrinsic pathway of blood coagulation. Serine protease that circulates in the blood in a zymogen form. Factor VII is converted to factor VIIa by factor Xa, factor XIIa, factor IXa, or thrombin by minor proteolysis. In the presence of tissue factor and calcium ions, factor VIIa then converts factor X to factor Xa by limited proteolysis. Factor VIIa will also convert factor IX to factor IXa in the presence of tissue factor and calcium.
-
Poids moléculaire
- 49-55 kDa
-
ID gène
- 2155
-
UniProt
- P08709
-
Pathways
- Response to Growth Hormone Stimulus, Platelet-derived growth Factor Receptor Signaling
Antigène
-